@article{b1364520c5354d8a848614e1ea8e8118,
title = "Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/ refractory indolent lymphoma",
author = "Cheah, {Chan Yoon} and Nastoupil, {Loretta J.} and Neelapu, {Sattva S.} and Forbes, {Sheryl G.} and Yasuhiro Oki and Fowler, {Nathan H.}",
note = "Funding Information: Acknowledgments: This study was sponsored by Gilead Sciences.",
year = "2015",
doi = "10.1182/blood-2015-03-633156",
language = "English (US)",
volume = "125",
pages = "3357--3359",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "21",
}